Skip to content
10-Q

Quarterly Report

Vilacto Bio Inc.

0001663577-18-000527

← back to feed
Filed
Nov 19, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Nov 19, 2018 98.5M sh
Operating Cash Flow Q2 2019 · Sep 30, 2018 −$296.24K
Operating Cash Flow Q2 2019 · Sep 30, 2017 −$100.15K
Cash And Equivalents Q2 2019 · Sep 30, 2018 $143.18K
Cash And Equivalents Q2 2019 · Mar 31, 2018 $148.77K
Cash And Equivalents Q2 2019 · Mar 31, 2017 $22.02K
Stockholders Equity Q2 2019 · Sep 30, 2018 −$3.21M
Stockholders Equity Q2 2019 · Mar 31, 2018 −$935.91K
Current Liabilities Q2 2019 · Sep 30, 2018 $3.49M
Current Liabilities Q2 2019 · Mar 31, 2018 $1.25M
Total Liabilities Q2 2019 · Sep 30, 2018 $3.49M
Total Liabilities Q2 2019 · Mar 31, 2018 $1.25M
Current Assets Q2 2019 · Sep 30, 2018 $270.12K
Current Assets Q2 2019 · Mar 31, 2018 $308.87K
Total Assets Q2 2019 · Sep 30, 2018 $283.52K
Total Assets Q2 2019 · Mar 31, 2018 $309.77K
Sga Expense Q2 2019 · Sep 30, 2018 $50.59K
Sga Expense Q2 2019 · Sep 30, 2018 $117.17K
Sga Expense Q2 2019 · Sep 30, 2017 $15.24K
Sga Expense Q2 2019 · Sep 30, 2017 $34.25K
Net Income Q2 2019 · Sep 30, 2018 −$2.32M
Net Income Q2 2019 · Sep 30, 2018 −$2.27M
Net Income Q2 2019 · Mar 31, 2018 $3.28M
Net Income Q2 2019 · Sep 30, 2017 −$58.86K
Net Income Q2 2019 · Sep 30, 2017 −$131.89K
Operating Income Q2 2019 · Sep 30, 2018 −$111.01K
Operating Income Q2 2019 · Sep 30, 2018 −$228.49K
Operating Income Q2 2019 · Sep 30, 2017 −$57.24K
Operating Income Q2 2019 · Sep 30, 2017 −$129.04K
Gross Profit Q2 2019 · Sep 30, 2018 $295
Gross Profit Q2 2019 · Sep 30, 2018 $495
Cost Of Revenue Q2 2019 · Sep 30, 2018 $655
Cost Of Revenue Q2 2019 · Sep 30, 2018 $885
Revenue Q2 2019 · Sep 30, 2018 $950
Revenue Q2 2019 · Sep 30, 2018 $1.38K